Security key
40637H109
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)
CUSIP: 40637H109
Q1 2015 13F Holders as of 31 Mar 2015
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 94,411,049
- Total 13F value
- $1,348,555,169
- Share change
- +3,013,922
- Put/Call ratio
- 70%
- SEC-reported price per share
- $14.28
- Number of holders
- 137
- Value change
- +$51,544,544
- Number of buys
- 80
- Number of sells
- 58
- Shares outstanding
- 118,494,184
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q1 2015
Institutions
137
Top holders
10
HALO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2015
Previous quarter: Q4 2014
HALOZYME THERAPEUTICS, INC. SEC filings
HALOZYME THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 40637H109
Recent filing periods:
Ownership snapshot
Top reported holders of HALO - HALOZYME THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Third Security, LLC
Disclosed value leader
Third Security, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2014
13F
Lead comparable stake: 17%
Showing 1-6 of 15 holder rows.
Quick read
Third Security, LLC leads the comparable SEC ownership view at 17%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Third Security, LLC
17%
IRIDIAN ASSET MANAGEMENT LLC/CT
6.1%
BB BIOTECH AG
5.8%
VANGUARD GROUP INC
5.3%
BlackRock Fund Advisors
3.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Third Security, LLC |
13F
Company
|
17%
|
$191,226,000
19,816,162 shares
|
— | 31 Dec 2014 |
| IRIDIAN ASSET MANAGEMENT LLC/CT |
13F
Company
|
6.1%
|
$70,195,000
7,274,065 shares
|
— | 31 Dec 2014 |
| BB BIOTECH AG |
13F
Company
|
5.8%
|
$65,866,000
6,825,532 shares
|
— | 31 Dec 2014 |
| VANGUARD GROUP INC |
13F
Company
|
5.3%
|
$60,647,000
6,284,638 shares
|
— | 31 Dec 2014 |
| BlackRock Fund Advisors |
13F
Company
|
3.5%
|
$39,592,000
4,102,773 shares
|
— | 31 Dec 2014 |
| First Eagle Investment Management, LLC |
13F
Company
|
3.4%
|
$38,508,000
3,990,480 shares
|
— | 31 Dec 2014 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2015
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
137
Shares
94,411,049
Rows available
137
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2015 vs Q4 2014 Across Filers
Q4 2014 holders
130
Q1 2015 holders
137
Holder diff
7
| Investor | Q4 2014 Shares | Q1 2015 Shares | Share Diff | Share Chg % | Q4 2014 value | Q1 2015 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend